Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$192M Sell
529,613
-15,848
-3% -$5.42M 0.23% 102
2026
Q1
$192M Buy
+545,461
New +$194M 0.26% 98
2025
Q3
$26.5M Buy
+93,962
New +$27.3M 0.15% 108

Other funds holding AMGN

CIBC Bancorp USA's AMGN Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Amgen (AMGN) stake by 2.9% in Q2 2026, selling an estimated $5.42M and leaving 529,613 shares worth $192M. The position accounts for 0.23% of the portfolio, ranked #102.

CIBC Bancorp USA first reported a position in AMGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $192M in Q1 2026. 3,029 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • CIBC Bancorp USA held 529,613 shares of Amgen worth $192M as of Q2 2026.
  • CIBC Bancorp USA sold 15,848 Amgen shares in Q2 2026, an estimated $5.42M.
  • Amgen made up 0.23% of CIBC Bancorp USA's portfolio in Q2 2026, its #102 holding.
  • CIBC Bancorp USA first reported a position in Amgen in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Amgen position peaked at $192M in Q1 2026.
  • 3,029 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.